Showing 1 - 7 results of 7 for search 'Julie Bulsei', query time: 0.03s
Refine Results
-
1
How to perform a cost-effectiveness analysis with surrogate endpoint: renal denervation in patients with resistant hypertension (DENERHTN) trial as an example by Julie Bulsei, Meryl Darlington, Isabelle Durand-Zaleski, Michel Azizi, The DENERHTN Study Group
Published 2018-03-01
Article -
2
-
3
Cost-effectiveness of 82-Rubidium PET myocardial perfusion imaging for the diagnosis of myocardial ischemia depending on the prevalence of coronary artery disease by Maroua Mimouni, Julie Bulsei, Meryl Darlington, Candice Estellat, François Rouzet, Fabien Hyafil, Isabelle Durand-Zaleski, the RUBIS Trial Group
Published 2023-02-01
Article -
4
SAME day amBulatory Appendectomy (SAMBA): a multicenter, prospective, randomized clinical trial protocol by Catherine Arvieux, Fatah Tidadini, Sandrine Barbois, Eric Fontas, Michel Carles, Victor Gridel, Jean-Christophe Orban, Jean-Louis Quesada, Alison Foote, Coralie Cruzel, Sabine Anthony, Julie Bulsei, Céline Hivelin, Damien Massalou
Published 2024-09-01
Article -
5
Correction: SAME day amBulatory Appendectomy (SAMBA): a multicenter, prospective, randomized clinical trial protocol by Catherine Arvieux, Fatah Tidadini, Sandrine Barbois, Eric Fontas, Michel Carles, Victor Gridel, Jean-Christophe Orban, Jean-Louis Quesada, Alison Foote, Coralie Cruzel, Sabine Anthony, Julie Bulsei, Céline Hivelin, Damien Massalou
Published 2024-09-01
Article -
6
Cost-effectiveness of lung volume reduction coil treatment in patients with severe emphysema: results from the 2-year follow-up crossover REVOLENS study (REVOLENS-2 study) by Julie Bulsei, Sylvie Leroy, Jeanne-Marie Perotin, Hervé Mal, Charles-Hugo Marquette, Hervé Dutau, Arnaud Bourdin, Jean-Michel Vergnon, Christophe Pison, Romain Kessler, Vincent Jounieaux, Mathieu Salaün, Armelle Marceau, Sylvain Dukic, Coralie Barbe, Margaux Bonnaire, Gaëtan Deslee, Isabelle Durand-Zaleski, the REVOLENS study group
Published 2018-05-01
Article -
7
Prostatic artery embolisation versus medical treatment in patients with benign prostatic hyperplasia (PARTEM): a randomised, multicentre, open-label, phase 3, superiority trialRese... by Marc Sapoval, Nicolas Thiounn, Aurélien Descazeaud, Carole Déan, Alain Ruffion, Gaële Pagnoux, Ricardo Codas Duarte, Grégoire Robert, Francois Petitpierre, Gilles Karsenty, Vincent Vidal, Thibaut Murez, Hélène Vernhet-Kovacsik, Alexandre de la Taille, Hicham Kobeiter, Romain Mathieu, Jean-Francois Heautot, Stéphane Droupy, Julien Frandon, Nicolas Barry Delongchamps, Virginie Korb-Savoldelli, Isabelle Durand-Zaleski, Helena Pereira, Gilles Chatellier, Olivier Pellerin, Brigitte Sabatier, Charles Dariane, Benjamin Gabay, Paul Cezar Moldovan, Olivier Rouvière, Jean Champagnac, Samuel Lagabrielle, Nicolas Grenier, Romain Boissier, Éric Lechevallier, Jalal-Jean Izaaryene, Farouk Tradi, Raphaele Arrouasse, Julien Defontaines, Xavier Joseph, Philippe Le Corvoisier, Emilie Sbidian, Cécile Champy, Mélanie Chiaradia, Armand Chevrot, Cyrille Blion, Jean Goupil, Julie Bulsei, Alexandra Vappereau
Published 2023-08-01
Article